Empowering biotechnology in southern Africa: Establishment of a robust transformation platform for the production of industry preferred cassava Chrissie.

Slides:



Advertisements
Similar presentations
Vietnam National University-HCM City University of Natural Sciences Technology transfer : Experiences in Department of Plant biotechnology & Biotransformation.
Advertisements

Biotechnology - Using an organism to make a product, …or using advanced methods to study an organism GMO - Genetically Modified Organism Transgenic - describing.
Genetically Modified Golden Bean Mosaic Virus Resistant Beans Michael Xie 12/2/14.
Biotechnology - traditional Modification by microorganisms of materials for human use Modification by microorganisms of materials for human use Use of.
Science and GMO-relevant technology Genes and genomes – last week –Genomes and their inheritance and variation –Genes and their structure –Important methods:
The Role of Agricultural Biotechnology in Africa’s Development Diran Makinde Director, West African Biosciences Network (WABNet) NEPAD Biosciences Initiative.
Figure 1. Development of golden mosaic disease in the common bean lines engineered for resistance to Bean golden mosaic virus mediated RNAi (T), compared.
Chapter 6 Plant Biotechnology. Plant Structure CO 2 + H 2 O →C 6 H 12 O 6 + O 2 Plant Structure.
Recombinant DNA & Biotechnology. Recombinant DNA recombinant DNA molecules contain DNA from different organisms –any two DNAs are joined by DNA ligase.
Ch. 9: Frontiers of Biotechnology
Genetically Modified Foods. What is a Genetically Modified (GM) Food? Foods that contain an added gene sequence Foods that contain an added gene sequence.
Genetically Modified Foods Ms. Gaynor Honors Genetics.
KEY CONCEPT DNA sequences of organisms can be changed.
Gene Technology Chapter 16.
Biotechnology SB2.f – Examine the use of DNA technology in forensics, medicine and agriculture.
Transfection. What is transfection? Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing.
Microbial Models I: Genetics of Viruses and Bacteria 7 November, 2005 Text Chapter 18.
An Ethical Debate.  Humans have been breeding farm animals for thousands of years  Selective breeding is done to get the traits a person wants.
Genetically Modified Foods. What is GMO’s Genetically modified organisms.
12.10 Gel electrophoresis sorts DNA molecules by size
KEY CONCEPT Biotechnology relies on cutting DNA at specific places.
Microbial Models I: Genetics of Viruses and Bacteria 8 November, 2004 Text Chapter 18.
Recombinant DNA and Cloning The Impact of Biotechnology Honors Genetics Ms. Susan Chabot Lemon Bay High School.
Genetically Modified Organisms (GMO) A Scientific Perspective Presentation to Portfolio Committee on Agriculture and Land Affairs 15 th November, 2005.
9.1 Manipulating DNA KEY CONCEPT Biotechnology relies on cutting DNA at specific places.
Genetic Engineering. Entire organisms can be cloned  Clone  a genetically identical copy of a gene or of an organism  Cloning occurs in nature:  Bacteria.
What is Biotechnology? How Long have humans used Biotechnology?
Genetically Modified Foods (GM or GMO foods). What is a Genetically Modified (GM) Food? Foods that contain an added gene sequence Foods that contain an.
Additional Transformation Topics
Plant Biotechnology: - why and how... Hélia Sales “Plants for Life” International PhD Program – 2016 (course “Plant Biotechnology for Sustainability and.
Elibariki, G; Njahira, M; Hosea, K.M.M; Skilton,R; Ndunguru, J
Techniques used in Genetic Engineering
Tissue Culture Tissue Culture is a method in which a few cells from the vegetative plant body are taken and kept in a nutrient medium.
Agricultural Biotechnology in Turkey
Biotechnology.
4/26/2010 BIOTECHNOLOGY.
Sijun Zhou and Daniel C.W. Brown
Relationship between Genotype and Phenotype
Virus Basics - part I Viruses are genetic parasites that are smaller than living cells. They are much more complex than molecules, but clearly not alive,
Warm-Up (12/01) On the piece of white paper from the back, answer the following question. Name Date Period How did the Hershey-Chase experiment prove.
Using artificial microRNAs to induce Cassava Brown Streak Disease resistance in cassava Henry Wagaba.
Exploiting the combination of natural and genetically engineered resistance to viruses impacting cassava production in Africa.
V. GENETIC TECHNOLOGY Genetically Modified Organisms
Option F Biotechnology and Microbes
Genetic Engineering 9/11/2018 SB2f.
Biotechnology Genetic Engineering.
C. Stander, K. Vasanth, M. Korkie and M.A. Vivier
Transformed explants grown on selective medium Transformation strategy
BREEDING AND BIOTECHNOLOGY
Biotechnology of GMOs: Genetically Modified Organisms
13–4 Applications of Genetic Engineering
Genetic Modification 3.5.
Technical Aspects of Recombinant DNA and Gene Cloning
Option B.2 - Biotechnology in Agriculture
New genes can be added to an organism’s DNA.
Genetically Modified Foods
Challenges in Biomedical Technology
Class: ENSC S-135 Biochemical Engineering and Synthetic Life
Gene Transfer, Genetic Engineering, and Genomics
Relationship between Genotype and Phenotype
Genes The basic unit of heredity Encode how to make a protein
Methods of Genetic Modification in Plants
Bioinformatics for plant biosecurity and surveillance systems
KEY CONCEPT DNA sequences of organisms can be changed.
ROLE OF KEPHIS IN SAFE HANDLING, TRANSFER AND USE OF GMOS.
More biomedical research challenges
KEY CONCEPT DNA sequences of organisms can be changed.
KEY CONCEPT DNA sequences of organisms can be changed.
KEY CONCEPT DNA sequences of organisms can be changed.
Stephan Winter & Marianne Koerbler
Presentation transcript:

Empowering biotechnology in southern Africa: Establishment of a robust transformation platform for the production of industry preferred cassava Chrissie Rey 1, Chezlyn Chetty 1, Claudia Rossin 1, Sarah Rogans 1, M Moralo 1, W Gruissem 2 and Herve Vanderschuren 2 1 Plant Biotechnology Programme School of Molecular and Cell Biology University of the Witwatersrand 2 Institute of Plant Sciences, ETH Zurich, C C Chetty, C B Rossin, W Gruissem, H Vanderschuren and M E C Rey New Biotechnology (published online 7 June 2012)

Hang out with an impala!

And to go with your beer

CASSAVA IN SOUTHERN AFRICA: FOOD, FEED AND STARCH Tonga tribesman growing cassava for hundreds of years Grown in SA, Swaziland and Mozambique for food security with maize; Casquip Starch Man.: commercial farm Potential of cassava for industrial starch (food, textile and paper) and bioethanol SAPPI and MONDE: paper SA Breweries for beer (Impala) T200: industry preferred high-starch landrace Cassava mosaic disease (CMD): most significant constraint of cassava production in southern Africa

CASSAVA IN SOUTHERN AFRICA: FOOD, FEED AND STARCH Tonga tribesman growing cassava for hundreds of years Grown in SA, Swaziland and Mozambique for food security with maize Potential of cassava for industrial starch (food, textile and paper) and bioethanol SAPPI and MONDE: paper SA Breweries for beer (Impala) T200: industry preferred high- starch landrace Cassava mosaic disease (CMD): most significant constraint of cassava production in southern Africa

Challenges for GM virus-resistant cassava Are 7 distinct viral species with limited sequence homology; three of these (ACMV, EACMV and SACMV) occur in SA High virus recombination rates lead to fast generation of biodiversity Mixtures of viruses in the field Uncontrolled movement of infected stakes between geographical regions (vegetative virus spread) High genetic diversity of the whitefly vector: SSAF 1-5; SSAF 1 main WF on cassava

Challenges for cassava transformation Need to engineer cassava for virus resistance and other traits Cassava is highly recalcitrant to transformation; transformation efficiencies low at ±5 - 15% Transformation system lacks reproducibility & flexibility; labor- intensive and fastidious Regeneration potential is also low Robust and reproducible system only for model lab cultivar 60444; limited success for farmer-preferred landraces or cultivars Few laboratories in the northern hemisphere have achieved success; no sustainable & reproducible platform/pipeline on African continent Knowledge & technology transfer to African labs offering less optimal conditions is needed

IMMUNITY: SCREEN FOR R GENES RECOVERY: siRNA CASSAVA RESEARCH PROGRAM TRANSGENICS: PTGS (siRNA & amiRNA) RESISTANCE BREAKING SATELLITES VIRUS DIVERSITY AND EVOLUTION WHITEFLY BIOTYPING AND GENOMICS CISGENICS SACMV EACMV ACMV

South African cassava mosaic virus Gene targets for silencing AC1- replication associated protein AC4 – silencing of host PTGS/symptom determinant AC2/AC3 - replication enhancer/ transcription enhancer BC1- cell-to-cell movement protein  Chimeric tandem constructs of ACMV, SACMV and EACMV

Approaches to genetic engineering  Antisense RNA  Hairpins (inverted repeats) to induce antiviral siRNAs (hpRNAi)  Inverted repeats with mismatches in the sense strand  Artificial miRNAs  Defective interfering molecules

Intron-containing long IR constructs not always stable: DNA in IR conformation can form 4-way helical junctions (cruciforms) Cruciforms are unstable & are key intermediates for homologous recombination Introduced bp mismatches (C - T) in the sense arm of SACMV Rep (AC1) & BC1 IRs, by sodium bisulphite treatment, preventing cruciforms, thermodynamic stabilization of DNA secondary structure and resulting RNA hairpin Filed PCT in Europe; SA patent Biotechniques 52(4):

Mismatched SACMV AC1 Real time qPCR results in Nicotiana benthamiana shows viral knockdown & reduced symptoms 3 classes of siRNA detected: 21, 24, and nt

miRNAs siRNAs RNA SILENCING Virus derived transgene silencing constructs Antisense Hairpins that produce siRNA (NMM;MM) amiRNA processed to produce antiviral siRNAs Agrobacterium-mediated or particle bombardment transformation of TMS60444 & T200 Somatic Embryo (SE) Friable Embryogenic callus (FEC) Developing somatic embryo Cotyledo n Transgenic plantlet GUS FEC GUS cotyledon Molecular Analysis MODIFIED METHOD DEVELOPED BY ETH ZURICH 8 months & 10 months for T200 ILL AB

Somatic Embryogenesis (SE) 3 cycles (6 weeks)10 weeks (5 cycles) SE cycles to generate friable embryogenic (FEC) 6 weeks (light)8-10 weeks (dark) FEC proliferationHighMedium/high Quality of FECsExcellentGood No. Transfers to CEM +C100 medium for shooting induction 24 cv T 200 Comparison of transformation process between model cultivar and T200, a SA landrace

Regeneration of cotyledons from wild-type untransformed FECs

Data for transformation, and regeneration of transformed FECs, for TMS and T200 Cumulative results from two parallel experiments, each starting with 70 FEC clusters. a Total number of putatively transformed cotyledons emerging from 140 FEC clusters. b Calculated as the number of shoots obtained on CEM divided by the number of putatively transformed cotyledons. c Calculated as the number of shoots that produced roots on selection media divided by the number of shoots that developed on CEM (represents percentage of transformed rooted/ shooted plantlets derived per plate per five FEC clusters). d. Number of transgenics from 140 FEC clusters. CultivarNo. germinated cotyledons a Shooting efficiency (%) b Percentage rooted plantlets c Transformation efficiency d cv T

Summary High transformation efficiencies for cv (45%) and SA cultivar T200 (33%); shooting of T200 needs improvement We have 6 acclimatized transgenic lines in greenhouse trials (SACMV BC1; AC1/AC4 SACMV (MM and NM) and AC1/AC4 & AC2/3 ACMV in TMS & T200) Testing other siRNA and amiRNA stacked constructs Constructed and testing minimal cassettes by biolistics for commercialization This research was a collaboration between Wits and ETH Zurich and emphasizes the importance of technology transfer between the hemispheres There is a need to establish CAPACITY and a sustainable, robust and reproducible CASSAVA TRANSFORMATION PLATFORM for GE on the African continent for other traits such as drought, nutritional fortification

Challenges Capacity training of a sustainable technical expertise base of critical mass Cassava transformation genotype dependent; 8-10 months to generate FEC Funding to set up a sustainable and robust cassava transformation pipeline/platform Despite GM legislation, process is slow, especially for new crops Field trial permit; biosafety and risk assessments Lack of expertise in SA and continent for commercialization Intellectual Property (IP) still faces challenges Private sector investment: commercial farmers Also target small-scale farmers

UNIVERSITY OF THE WITWATERSRAND Thank NRF, Casquip Starch Manufacturing Co. and TIA for funding; and for support from the SA-Swiss S&T Bilateral Programme

RNA SILENCING: PLANT INNATE IMMUNITY